Denali Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.3M | 437k | 14.52 |
| 2025-06-30 | $6.0M | 426k | 13.99 |
| 2025-03-31 | $3.3M | 241k | 13.59 |
| 2024-12-31 | $5.7M | 278k | 20.38 |
| 2024-09-30 | $7.5M | 256k | 29.13 |
| 2024-06-30 | $3.0M | 127k | 23.23 |
| 2024-03-31 | $3.1M | 152k | 20.52 |
| 2023-12-31 | $7.9M | 369k | 21.46 |
| 2023-09-30 | $3.4M | 167k | 20.63 |
| 2023-06-30 | $4.7M | 159k | 29.51 |
| 2023-03-31 | $15M | 656k | 23.04 |
| 2022-12-31 | $16M | 586k | 27.81 |
| 2022-09-30 | $10M | 326k | 30.69 |
| 2022-06-30 | $11M | 369k | 29.43 |
| 2022-03-31 | $1.9M | 58k | 32.17 |
| 2021-12-31 | $5.4M | 121k | 44.59 |
| 2021-09-30 | $3.6M | 71k | 50.45 |
| 2021-06-30 | $1.9M | 24k | 78.48 |
| 2021-03-31 | $5.1M | 90k | 57.09 |
| 2020-12-31 | $1.9M | 23k | 83.79 |
| 2020-09-30 | $1.0M | 29k | 35.85 |
| 2020-06-30 | $860k | 36k | 24.16 |
| 2020-03-31 | $314k | 18k | 17.49 |
| 2019-12-31 | $848k | 49k | 17.42 |
| 2019-09-30 | $681k | 45k | 15.32 |
| 2019-06-30 | $642k | 31k | 20.77 |
| 2019-03-31 | $319k | 14k | 23.22 |
| 2018-09-30 | $371k | 17k | 21.73 |
| 2018-06-30 | $19k | 1.2k | 15.35 |
| 2018-03-31 | $65k | 3.3k | 19.48 |